Management of central serous chorioretinopathy: Expert panel discussion

被引：5

作者：

Chhablani, Jay ^{[1
]}

Anantharaman, Giridhar ^{[2
]}

Behar-Cohen, Francine ^{[3
,4
,5
,6
]}

Boon, Camiel ^{[7
,8
]}

Manayath, George ^{[9
]}

Singh, Rishi ^{[10
]}

机构：

[1] LV Prasad Eye Inst, Smt Kanuri Santhamma Ctr Vitreoretinal Dis, Banjara Hills, Hyderabad 500034, Telangana, India

[2] Giridhar Eye Inst, Dept Vitreoretinal Serv, Cochin, Kerala, India

[3] Univ Lausanne, Dept Ophthalmol, Jules Gonin Eye Hosp, Fdn Asile des Aveugles, Lausanne, Switzerland

[4] UPMC Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, Team 1 & 17, Paris, France

[5] Ctr Rech Cordeliers, INSERM, Paris, France

[6] Univ Paris 05, Sorbonne Paris Cite, Ctr Rech Cordeliers, Paris, France

[7] Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands

[8] Univ Amsterdam, Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands

[9] Aravind Eye Hosp, Dept Retina & Ocular Oncol, Coimbatore, Tamil Nadu, India

[10] Cole Eye Inst, Cleveland, OH USA

来源：

INDIAN JOURNAL OF OPHTHALMOLOGY | 2018年 / 66卷 / 12期

关键词：

Central serous chorioretinopathy; management; choroid; retina; expert panel;

D O I：

10.4103/ijo.IJO_1411_18

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Central serous chorioretinopathy (CSCR), one of the most common diseases in retina clinics, needs a special attention by retina specialists. Considering the challenges in diagnosis, classification, and management of this enigmatic disease and lack of level 1 evidence, there is a need for consensus with regard to establishing management protocols.

引用

页码：1700 / 1703

页数：4

共 50 条

[21] Cystoid macular degeneration in chronic central serous chorioretinopathy
Iida, T
Yannuzzi, LA
Spaide, RF
Borodoker, N
Carvalho, CA
Negrao, S
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2003, 23 (01): : 1 - 7
[22] Oral eplerenone for the management of chronic central serous chorioretinopathy
Singh, Rishi P.
Sears, Jonathan E.
Bedi, Rumneek
Schachat, Andrew P.
Ehlers, Justis P.
Kaiser, Peter K.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2015, 8 (02) : 310 - 314
[23] Finasteride for Chronic Central Serous Chorioretinopathy
Fujikawa, Kelly
Patel, Amar P.
Morse, Lawrence S.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
[24] Oral eplerenone for the management of chronic central serous chorioretinopathy
Rishi P Singh
Jonathan E Sears
Rumneek Bedi
Andrew P Schachat
Justis P Ehlers
Peter K Kaiser
International Journal of Ophthalmology, 2015, (02) : 310 - 314
[25] FAMILIAL CENTRAL SEROUS CHORIORETINOPATHY
van Dijk, Elon H. C.
Schellevis, Rosa L.
Breukink, Myrte B.
Mohabati, Danial
Dijkman, Greet
Keunen, Jan E. E.
Yzer, Suzanne
Den Hollander, Anneke I.
Hoyng, Carel B.
de Jong, Eiko K.
Boon, Camiel J. F.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (02): : 398 - 407
[26] Brachytherapy for Central Serous Chorioretinopathy
Supriya Arora
Baldassarre D. Stea
Russell J. Hamilton
Jay Chhablani
Ophthalmology and Therapy, 2022, 11 : 1611 - 1616
[27] Central serous chorioretinopathy: A review
Bousquet, E.
Provost, J.
Torres-Villaros, H.
Behar-Cohen, F.
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2023, 46 (07): : 791 - 802
[28] Masqueraders of central serous chorioretinopathy
Sahoo, Niroj Kumar
Singh, Sumit Randhir
Rajendran, Anand
Shukla, Dhananjay
Chhablani, Jay
SURVEY OF OPHTHALMOLOGY, 2019, 64 (01) : 30 - 44
[29] Central serous chorioretinopathy: Treatment
Park, Jong
Kim, Kiyoung
Kang, Min
Kim, Eung
Yu, Seung-Young
TAIWAN JOURNAL OF OPHTHALMOLOGY, 2022, 12 (04) : 394 - 408
[30] Central serous chorioretinopathy (CSC)
Baraki, H.
Feltgen, N.
Roider, J.
Hoerauf, H.
Klatt, C.
OPHTHALMOLOGE, 2010, 107 (05): : 479 - 492

← 1 2 3 4 5 →